Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment
- PMID: 32607030
- PMCID: PMC7319523
- DOI: 10.2147/RMHP.S231075
Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment
Abstract
Purpose: Cardiovascular disease (CVD) risk assessment is an important strategy for the prevention of CVD. Pharmacists play an important role in CVD risk assessment and management (CVDRAM). Our previous study identified gaps in knowledge among community pharmacists for the provision of CVDRAM services as assessed through patient simulation. Therefore, our objectives were: a) to develop and evaluate an educational program on CVD risk assessment for community pharmacists, b) to assess the knowledge and skills of participating pharmacists in assessing and managing CVD risk before and after enrolling in the educational program and c) to explore pharmacists' satisfaction and perceived effectiveness of the educational program.
Methods: Using a blended learning instructional approach, the educational program for a subset of 25 community pharmacists recruited from our previous study consisted of two face-to-face workshops, and an online 5-module course on CVD risk factors such as hyperlipidemia, hypertension, diabetes, obesity, and smoking cessation based on principles of adult learning. A repeated measures study design was utilized by measuring participants' knowledge on pre- and post-questionnaires and an objective structured clinical examination (OSCE) at the conclusion of the educational program was also used to assess its impact on the knowledge and skills of community pharmacists in the provision of CVD risk assessment and management (CVDRAM) services. The knowledge questionnaire was completed by 23 pharmacists while the OSCE was completed by 8 pharmacists. In addition, a survey assessed the pharmacists' level of satisfaction with the educational program.
Results: At the conclusion of the educational program, the participating pharmacists achieved knowledge and skills for the provision of CVDRAM services. Knowledge scores in relation to CVDRAM significantly improved after the educational program [out of a maximum of 20 points, the median (interquartile range) = 9 (7-9) at pre- vs 12 (12-13) at post-educational program], p<0.001. On the OSCE, the median (interquartile range) scores for Stations 1 and 2 were 66 (63-71) and 71 (67-76), respectively. Out of the 21 pharmacists that completed the satisfaction survey, 71% were very satisfied and 29% were satisfied with the educational program.
Conclusion: The educational program improved pharmacists' knowledge and skills for the provision of CVDRAM services.
Keywords: cardiovascular disease risk assessment; community pharmacists; educational program; evaluation; pharmacists’ preparedness.
© 2020 Zolezzi et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures


Similar articles
-
Evaluation of community pharmacists' preparedness for the provision of cardiovascular disease risk assessment and management services: A study with simulated patients.Res Social Adm Pharm. 2019 Mar;15(3):252-259. doi: 10.1016/j.sapharm.2018.04.032. Epub 2018 Apr 28. Res Social Adm Pharm. 2019. PMID: 29753643
-
Perceived Preparedness of Health Care Students for Providing Cardiovascular Disease Risk Assessment and Management.Pharmacy (Basel). 2017 Feb 21;5(1):9. doi: 10.3390/pharmacy5010009. Pharmacy (Basel). 2017. PMID: 28970420 Free PMC article.
-
A web-based training program to support chronic kidney disease screening by community pharmacists.Int J Clin Pharm. 2016 Oct;38(5):1080-6. doi: 10.1007/s11096-016-0330-5. Epub 2016 Jun 21. Int J Clin Pharm. 2016. PMID: 27329381
-
Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.Res Social Adm Pharm. 2020 Feb;16(2):149-159. doi: 10.1016/j.sapharm.2019.04.009. Epub 2019 Apr 16. Res Social Adm Pharm. 2020. PMID: 31027964
-
Impact of a blended learning program on community pharmacists' barriers, knowledge, and counseling practice with regard to preconception, pregnancy and lactation.Res Social Adm Pharm. 2021 Jul;17(7):1242-1249. doi: 10.1016/j.sapharm.2020.09.009. Epub 2020 Sep 15. Res Social Adm Pharm. 2021. PMID: 32952090
Cited by
-
Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?J Pharm Policy Pract. 2021 May 6;14(1):42. doi: 10.1186/s40545-021-00319-6. J Pharm Policy Pract. 2021. PMID: 33958004 Free PMC article.
-
Concordance of the cardiovascular patient education with the principles of Andragogy model.Arch Public Health. 2022 Jan 4;80(1):4. doi: 10.1186/s13690-021-00763-5. Arch Public Health. 2022. PMID: 34983640 Free PMC article.
-
Development and evaluation of an online training program based on the O-AMAS teaching model for community pharmacists in the post-COVID-19 era.Front Public Health. 2022 Sep 23;10:906504. doi: 10.3389/fpubh.2022.906504. eCollection 2022. Front Public Health. 2022. PMID: 36211685 Free PMC article.
-
Experiences of patient education among people affected by cardiovascular disease: a qualitative study based on Andragogy model.BMC Health Serv Res. 2023 Jun 29;23(1):708. doi: 10.1186/s12913-023-09622-1. BMC Health Serv Res. 2023. PMID: 37386425 Free PMC article.
-
Role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in Malaysia: A nationwide cross-sectional study.PLoS One. 2023 Sep 28;18(9):e0290883. doi: 10.1371/journal.pone.0290883. eCollection 2023. PLoS One. 2023. PMID: 37768930 Free PMC article.
References
-
- WHO. Cardiovascular diseases. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...). Accessed February17, 2019.
-
- WHO. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. 2007. Available from: http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH.A.... Accessed September15, 2018.
-
- Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481–1492. doi:10.1161/01.CIR.100.13.1481 - DOI - PubMed
-
- Cardiovascular disease risk assessment for primary prevention: our approach. 2019. Available from: https://www.uptodate.com/contents/cardiovascular-disease-risk-assessment.... Accessed February10, 2019.
LinkOut - more resources
Full Text Sources